These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25716817)

  • 1. [Current Topics on Vitamin D. Combined therapy of anti-resorptive drug and active vitamin D].
    Endo I
    Clin Calcium; 2015 Mar; 25(3):433-8. PubMed ID: 25716817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.
    Stokkers PC; Deley M; Van Der Spek M; Verberne HJ; Van Deventer SJ; Hommes DW
    Scand J Gastroenterol; 2006 Feb; 41(2):200-4. PubMed ID: 16484125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis].
    Miki T; Okamoto K
    Clin Calcium; 2014 Sep; 24(9):1387-92. PubMed ID: 25177012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review.
    Jayasena A; Atapattu N; Lekamwasam S
    Int J Rheum Dis; 2015 Mar; 18(3):287-93. PubMed ID: 25923606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.
    Castro-Lionard K; Dargent-Molina P; Fermanian C; Gonthier R; Cassou B
    Drugs Aging; 2013 Dec; 30(12):1029-38. PubMed ID: 24114665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucocorticoid induced osteoporosis].
    Anić B; Mayer M
    Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic treatment of osteoporosis--2011].
    Lakatos P
    Orv Hetil; 2011 Aug; 152(33):1320-6. PubMed ID: 21824859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis - pharmacological prevention and management in older people.
    Bell JS; Blacker N; Edwards S; Frank O; Alderman CP; Karan L; Husband A; Rowett D
    Aust Fam Physician; 2012 Mar; 41(3):110-8. PubMed ID: 22396923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits.
    Leung TF; Chu Y; Lee V; Cheng FW; Leung WK; Shing MM; Li CK
    Hemoglobin; 2009; 33(5):361-9. PubMed ID: 19814683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of calcium and vitamin D supplementation in bisphosphonate therapy.
    Rush DN; Jones MW; Futrell DP; Futrell WR; McDowell JO; Ferreri SP
    J Am Pharm Assoc (2003); 2007; 47(6):725-8. PubMed ID: 18032135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonates first-line pharmacological treatment].
    Wallander M; Ljunggren Ö; Lorentzon M
    Lakartidningen; 2016 Nov; 113():. PubMed ID: 27824394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bisphosphonate].
    Hagino H
    Nihon Rinsho; 2015 Oct; 73(10):1683-9. PubMed ID: 26529930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of osteoporosis.
    Lash RW; Nicholson JM; Velez L; Van Harrison R; McCort J
    Prim Care; 2009 Mar; 36(1):181-98, x. PubMed ID: 19231609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bisphosphonate or Raloxifene?: which drug we can choose for osteoporotic patients?].
    Miki T; Saito S
    Clin Calcium; 2006 Jan; 16(1):167-74. PubMed ID: 16397368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.